These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 834317)
41. Subsensitivity of striatal and mesolimbic dopamine target cells after repeated treatment with apomorphine dipivaloyl ester. Scatton B; Worms P Naunyn Schmiedebergs Arch Pharmacol; 1978 Jul; 303(3):271-8. PubMed ID: 567284 [TBL] [Abstract][Full Text] [Related]
42. Neuroleptic-like effects of the l-isomer of fenfluramine on striatal dopamine release in freely moving rats. Bettini E; Ceci A; Spinelli R; Samanin R Biochem Pharmacol; 1987 Jul; 36(14):2387-91. PubMed ID: 2886127 [TBL] [Abstract][Full Text] [Related]
43. Effect of clozapine on the turnover of dopamine in the corpus striatum and in the limbic system. Andén NE; Stock G J Pharm Pharmacol; 1973 Apr; 25(4):346-8. PubMed ID: 4146695 [No Abstract] [Full Text] [Related]
44. Effect of drugs used in psychoses on cerebral dopamine metabolism. O'Keeffe R; Sharman DF; Vogt M Br J Pharmacol; 1970 Feb; 38(2):287-304. PubMed ID: 4984801 [TBL] [Abstract][Full Text] [Related]
45. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment. Nomura Y; Komori T; Okuda S; Segawa T Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):25-30. PubMed ID: 485682 [TBL] [Abstract][Full Text] [Related]
46. Effects of risperidone on phencyclidine-induced behaviors: comparison with haloperidol and ritanserin. Kitaichi K; Yamada K; Hasegawa T; Furukawa H; Nabeshima T Jpn J Pharmacol; 1994 Oct; 66(2):181-9. PubMed ID: 7532732 [TBL] [Abstract][Full Text] [Related]
47. Acute and chronic effects of haloperidol on plasma and brain homovanillic acid in the rat. Chang WH; Yeh EK; Hu WH; Tseng YT; Chung MC; Chang HF Biol Psychiatry; 1986 Apr; 21(4):374-81. PubMed ID: 3955111 [TBL] [Abstract][Full Text] [Related]
48. Chronic haloperidol treatment with low doses may enhance the increase of homovanillic acid in rat brain. Chang WH; Jaw SS; Tsay L Eur J Pharmacol; 1989 Mar; 162(1):151-6. PubMed ID: 2721561 [TBL] [Abstract][Full Text] [Related]
49. Dopamine metabolites and catalepsy after lithium and haloperidol. Bowers MB; Rozitis A Eur J Pharmacol; 1982 Feb; 78(1):113-5. PubMed ID: 7200429 [TBL] [Abstract][Full Text] [Related]
50. Influence of drugs on striatal and limbic homovanillic acid concentration in the rat brain. Westerink BH; Korf J Eur J Pharmacol; 1975 Aug; 33(1):31-40. PubMed ID: 126169 [TBL] [Abstract][Full Text] [Related]
51. Differential effect of haloperidol on dopamine release and metabolism in caudate putamen and anteromedial frontal cortex using intracerebral dialysis. Kurata K; Shibata R Pharmacology; 1991; 42(1):1-9. PubMed ID: 2057516 [TBL] [Abstract][Full Text] [Related]
52. [Increased tolerance of the dopamine- and serotoninergic systems during chronic administration of haloperidol and levomepromazine]. Allikmets LKh; Zharkovskiĭ AM; Otter MIa; Khinrikus TKh Zh Vyssh Nerv Deiat Im I P Pavlova; 1979; 29(5):1067-70. PubMed ID: 573939 [TBL] [Abstract][Full Text] [Related]
54. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol. Andersen HL; Kilpatrick IC Br J Pharmacol; 1996 May; 118(2):421-7. PubMed ID: 8735647 [TBL] [Abstract][Full Text] [Related]
55. L-dopa esters as potential prodrugs: effect on brain concentration of dopamine metabolites in reserpinized mice. Cooper DR; Marrel C; van de Waterbeemd H; Testa B; Jenner P; Marsden CD J Pharm Pharmacol; 1987 Oct; 39(10):809-18. PubMed ID: 2891818 [TBL] [Abstract][Full Text] [Related]
57. Effect of various centrally acting drugs on the efflux of dopamine metabolites from the rat brain. Westerink BH; Kikkert RJ J Neurochem; 1986 Apr; 46(4):1145-52. PubMed ID: 3950621 [TBL] [Abstract][Full Text] [Related]
58. Comparison of effects of drugs on dopamine metabolism in the substantia nigra and the corpus striatum of rat brain. Westerink BH; Korf J Eur J Pharmacol; 1976 Nov; 40(1):131-6. PubMed ID: 991922 [TBL] [Abstract][Full Text] [Related]
59. Treatment schedule as a determinant of the development of tolerance to haloperidol. Carey RJ; DeVeaugh-Geiss J Psychopharmacology (Berl); 1984; 82(3):164-7. PubMed ID: 6425895 [TBL] [Abstract][Full Text] [Related]
60. Tolerance to haloperidol-induced increases in dopamine metabolites: fact or artifact? Finlay JM; Jakubovic A; Fu DS; Fibiger HC Eur J Pharmacol; 1987 May; 137(1):117-21. PubMed ID: 3609130 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]